Buy & Sell Bath & Body Works Inc (BBWI) – Bath & Body Works Inc Price Today
Aura AI Summary
Key Stats
- $3.58BMarket Cap
- Consumer CyclicalSector
- -29.99%3M Drawdown
- $7.58BEnterprise Value
- 4.5%Dividend Yield
- 27% Buy | 73% SellTrading Activity
- 60 daysTypical Hold Time
Bath & Body Works Inc (BBWI) is currently valued at a market capitalization of $3.58B, with an enterprise value of $7.58B. Over the past 52 weeks, Bath & Body Works Inc has traded between a low of $14.85 and a high of $33.65, highlighting its annual price range. Over the past three months, Bath & Body Works Inc has recorded a drawdown of -29.99%, reflecting recent price volatility. Bath & Body Works Inc offers a dividend yield of 4.5%, with the most recent dividend of $0.20 paid on 20 Feb 26. On average, investors hold Bath & Body Works Inc for approximately 60 days, indicating typical investor behavior on the platform.
About Bath & Body Works Inc
Bath & Body Works is a specialty home fragrance and fragrant body care retailer operating under the Bath & Body Works, C.O. Bigelow, and White Barn brands. The company generates most of its business in North America, with less than 5% of sales from international markets in fiscal 2021. For fiscal 2021, 72% of sales stemmed from the brick-and-mortar network (which is composed of more than 1,700 retail stores), up from 65% in 2020, as consumer shopping patterns began to return to normal. Future growth is expected from store reformatting, digital and international channels, as well as new category expansion.
Most Recent News
ISS wins 7-year contract to provide 25,000 daily school meals in West Sussex, UK
ISS has secured a seven-year contract with West Sussex County Council to deliver around 25,000 nutritious school meals daily to primary schools starting Q3 2026. The contract, valued at about DKK 100 million annually, emphasizes inclusivity and high ...
argenx to present at major investor conferences in June, highlighting growth and new treatments.
argenx, a global immunology company focused on autoimmune diseases, announced its management team will present at two key investor conferences in June: the William Blair 46th Annual Growth Stock Conference and the Goldman Sachs 47th Annual Global Hea...
Capgemini targets 5.5-7.5% revenue CAGR by 2028, driven by AI transformation and margin expansion.
Capgemini announced its strategic direction focused on leveraging agentic AI to drive enterprise-wide transformation and business value. The company aims for a 5.5% to 7.5% compound annual revenue growth rate from 2025 to 2028, with margin expansion ...